|
Volumn 7, Issue 1, 2001, Pages 108-113
|
Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
a,b,c a a a a a,b,d a e a a a a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 NITROTYROSINE;
ENZYME INHIBITOR;
GLUCOSE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE;
N (6 OXO 5,6 DIHYDRO PHENANTHRIDIN 2 YL) N,N DIMETHYLACETAMIDE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
NITROGEN;
REACTIVE OXYGEN METABOLITE;
STREPTOZOCIN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BLOOD VESSEL REACTIVITY;
CELL FUNCTION;
CONTROLLED STUDY;
DIABETES MELLITUS;
DNA STRAND BREAKAGE;
DRUG EFFECT;
ENDOTHELIUM CELL;
ENDOTHELIUM LESION;
ENZYME ACTIVATION;
HYPERGLYCEMIA;
MALE;
MOUSE;
NONHUMAN;
PANCREAS ISLET CELL;
PATHOGENESIS;
PRIORITY JOURNAL;
STREPTOZOCIN DIABETES;
VASODILATATION;
ANIMALS;
DIABETES MELLITUS, EXPERIMENTAL;
ENDOTHELIUM, VASCULAR;
ENZYME ACTIVATION;
GLUCOSE;
IMMUNOHISTOCHEMISTRY;
MICE;
NF-KAPPA B;
POLY(ADP-RIBOSE) POLYMERASES;
ANIMALIA;
|
EID: 0035136240
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/83241 Document Type: Article |
Times cited : (582)
|
References (45)
|